Clearance Summary
PRINCETON BIOMEDIX URICASE (UV) received FDA 510(k) clearance under submission number K780859, sponsored by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1978-07-27.
- Submission: K780859
- Applicant / Sponsor: Bd Becton Dickinson Vacutainer Systems Preanalytic
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1775
- Decision date: 1978-07-27
Classification & Regulation
This clearance is catalogued under FDA product code CDO and 21 CFR 862.1775, within the Clinical Chemistry review panel as a Class I device.